ADMA Biologics, Inc. (ADMA) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$60,988
Total Return
509.88%
CAGR
43.57%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +4.35% |
| Median | +2.20% |
| Best | +54.84% |
| Worst | -47.13% |
| % of Windows Positive | 54.8% |
1-Year (252 Trading Days)
| Average | +112.48% |
| Median | +85.45% |
| Best | +524.86% |
| Worst | -59.00% |
| % of Windows Positive | 87.3% |
3-Year (756 Trading Days)
| Average | +775.87% |
| Median | +725.41% |
| Best | +1717.55% |
| Worst | +167.42% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -66.18% |
| Average Drawdown | -17.07% |
| Drawdown Duration | 241 Trading Days (Unrecovered) |
| Sortino Ratio | 1.44 |
| Calmar Ratio | 0.66 |
| CVaR (5%) | -7.53% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -42.49% (-85.67% ann.) | $4248.90 | $0.00 | $0.00 | $0.00 |
| 2025 | +6.36% | +$635.57 | $0.00 | $0.00 | $0.00 |
| 2024 | +279.42% | +$27942.48 | $0.00 | $0.00 | $0.00 |
| 2023 | +16.49% | +$1649.49 | $0.00 | $0.00 | $0.00 |
| 2022 | +175.18% | +$17517.77 | $0.00 | $0.00 | $0.00 |
| 2021 | -27.69% | $2769.24 | $0.00 | $0.00 | $0.00 |
| 2020 | -51.25% | $5125.00 | $0.00 | $0.00 | $0.00 |
| 2019 | +67.36% | +$6736.40 | $0.00 | $0.00 | $0.00 |
| 2018 | -25.55% | $2554.53 | $0.00 | $0.00 | $0.00 |
| 2017 | -37.30% | $3730.46 | $0.00 | $0.00 | $0.00 |
| 2016 | -36.56% | $3655.52 | $0.00 | $0.00 | $0.00 |
| 2015 | -27.75% | $2775.29 | $0.00 | $0.00 | $0.00 |
| 2014 | +43.21% | +$4320.51 | $0.00 | $0.00 | $0.00 |
| 2013 partial | -8.77% (-36.05% ann.) | $877.19 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | October 17, 2013 – February 19, 2020 | -54.74% | -11.75% | $5473.68 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -22.14% | -94.25% | $2213.73 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -33.68% | -48.36% | $3368.05 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -19.89% | -18.97% | $1988.94 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +78.99% | +85.54% | +$7898.50 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +493.97% | +161.49% | +$49396.83 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -45.70% | -32.25% | $4570.39 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.